drugset / Trial / NCT00730665
Efficacy And Safety Of PF-00885706 For The Relief Of Symptoms In Subjects With Gastro-esophageal Reflux Disease (GERD)
RandomizedParallel-groupTriple-blindTreatment
Summary
To understand the dose-response characteristics of PF-00885706 for efficacy in terms of symptomatic relief when used as add-on treatment to esomeprazole 20mg (standard proton pump inhibitor \[PPI\] treatment), in subjects with gastro-esophageal reflux (GERD) who have inadequate relief with PPIs.
Timeline
- Start
- 2008-01
- Primary completion
- 2008-10
- Completion
- 2008-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-00885706 | Unknown | 100 ug | — |
| Subject | PF-00885706 | Unknown | 300 ug | — |
| Subject | PF-00885706 | Unknown | 1 mg | — |
| Subject | PF-00885706 | Unknown | 3 mg | — |
| Comparator | Esomeprazole | Small molecule | 20 mg | — |